Now showing items 1-3 of 3

    • Anionogenic groups and surface sialoglycoconjugate structures of yeast forms of the human pathogen Paracoccidioides brasiliensis 

      Soares, Regina MA; Silva-Filho, Fernando Costa; Rozental, Sonia; Angluster, Jayme; Souza, Wanderley de; Alviano, Celuta Sales; Travassos, Luiz Rodolpho [UNIFESP] (Soc General Microbiology, 1998-02-01)
      The surface anionogenic groups and sialoglycoconjugate structures of Paracoccidioides brasiliensis yeast forms were analysed by cell microelectrophoresis, binding assays with lectins and viral particles, ultrastructural ...

    • Influenza virus surveillance among young children in São Paulo, Brazil: the impact of vaccination 

      Cabeça, Tatiane Karen [UNIFESP]; Watanabe, Aripuanã Sakurada Aranha [UNIFESP]; Moreira, Luciana Peniche [UNIFESP]; Melchior, Thaís Boim [UNIFESP]; Perosa, Ana Helena Sitta [UNIFESP]; Camargo, Clarice Neves [UNIFESP]; Parmezan, Sheila Negrini [UNIFESP]; Bellei, Nancy Cristina Junqueira [UNIFESP] (Sociedade Brasileira de Microbiologia, 2014-09-01)
      This study assessed the presence of influenza virus among young children and the coverage of vaccination from 2010 to 2012 in São Paulo, Brazil. Our results demonstrated a lower rate of influenza detection and a predominance ...

    • Relative Efficacy of AS03-Adjuvanted Pandemic Influenza A(H1N1) Vaccine in Children: Results of a Controlled, Randomized Efficacy Trial 

      Nolan, Terry; Roy-Ghanta, Sumita; Montellano, May; Weckx, Lily [UNIFESP]; Ulloa-Gutierrez, Rolando; Lazcano-Ponce, Eduardo; Kerdpanich, Angkool; Palazzi Safadi, Marco Aurelio; Cruz-Valdez, Aurelio; Litao, Sandra [UNIFESP]; Lim, Fong Seng; Mascarenas de Los Santos, Abiel; Rodriguez Weber, Miguel Angel; Tinoco, Juan-Carlos; Hernandez-de Mezerville, Marcela; Faingezicht, Idis; Kosuwon, Pensri; Lopez, Pio; Borja-Tabora, Charissa; Li, Ping; Durviaux, Serge; Fries, Louis; Dubin, Gary; Breuer, Thomas; Innis, Bruce L.; Vaughn, David W. (Oxford Univ Press Inc, 2014-08-15)
      Background. the vaccine efficacy (VE) of 1 or 2 doses of AS03-adjuvanted influenza A(H1N1) vaccine relative to that of 2 doses of nonadjuvanted influenza A(H1N1) vaccine in children 6 months to <10 years of age in a ...